investorscraft@gmail.com

Intrinsic ValuePlatz Co., Ltd. (7813.T)

Previous Close¥807.00
Intrinsic Value
Upside potential
Previous Close
¥807.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Platz Co., Ltd. operates in Japan's medical and nursing care equipment sector, specializing in the production and distribution of care beds, mattresses, and related accessories. The company serves a niche market, supplying retailers of medical devices, nursing care goods, and furniture shops. Its product portfolio includes nursing care beds, hospital beds, and reclining beds, catering primarily to healthcare facilities and elderly care providers. Platz Co. maintains a focused presence in Japan, leveraging its expertise in ergonomic and functional care solutions. The company’s market positioning is reinforced by its long-standing industry presence, having been incorporated in 1992 and rebranded in 1995. While it operates in a competitive segment dominated by larger medical equipment manufacturers, Platz Co. differentiates itself through specialized product offerings and localized distribution channels. The aging population in Japan presents a steady demand driver for its products, though the company faces challenges from pricing pressures and evolving regulatory standards in the healthcare sector.

Revenue Profitability And Efficiency

For the fiscal year ending June 2024, Platz Co. reported revenue of ¥6.39 billion, with net income of ¥65.7 million, reflecting modest profitability. The diluted EPS stood at ¥18.52, indicating limited earnings power relative to its market capitalization. Operating cash flow was ¥392.4 million, while capital expenditures were minimal at ¥29.3 million, suggesting restrained reinvestment in growth initiatives.

Earnings Power And Capital Efficiency

The company’s earnings power appears constrained, with net income representing a slim margin of approximately 1% of revenue. Operating cash flow, though positive, does not significantly exceed capital expenditures, indicating limited free cash flow generation. The balance between debt and cash reserves suggests a cautious approach to leveraging, with total debt nearly matching cash and equivalents.

Balance Sheet And Financial Health

Platz Co. holds ¥2.06 billion in cash and equivalents against ¥2.1 billion in total debt, resulting in a near-neutral net debt position. This balance sheet structure implies moderate financial flexibility, though the high debt load relative to earnings could pose risks if profitability further declines. The absence of aggressive leverage suggests a conservative financial strategy.

Growth Trends And Dividend Policy

Growth trends appear subdued, with no significant capital expenditure activity signaling expansion. The company pays a dividend of ¥14 per share, offering a modest yield, likely appealing to income-focused investors. However, the lack of robust revenue or earnings growth limits the potential for dividend increases in the near term.

Valuation And Market Expectations

With a market capitalization of ¥2.61 billion, Platz Co. trades at a price-to-sales ratio of approximately 0.4x, reflecting subdued market expectations. The low beta of 0.486 suggests relative stability but also limited alignment with broader market movements, typical for niche healthcare equipment providers.

Strategic Advantages And Outlook

Platz Co.’s strategic advantages lie in its specialized product line and entrenched position in Japan’s care equipment market. However, the outlook remains cautious due to competitive pressures and demographic reliance on an aging population. The company’s ability to innovate or expand beyond its core market will be critical for long-term sustainability.

Sources

Company filings, market data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount